




Searching News Database: Intellia Therapeutics
HSMN NewsFeed - 26 Jan 2022
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
HSMN NewsFeed - 18 Sep 2017
Abide Therapeutics Appoints Dr. Sapna Srivastava As Chief Financial and Strategy Officer
Abide Therapeutics Appoints Dr. Sapna Srivastava As Chief Financial and Strategy Officer
HSMN NewsFeed - 23 May 2017
IFM Therapeutics Appoints H. Martin Seidel as Executive Vice President of Research and Development
IFM Therapeutics Appoints H. Martin Seidel as Executive Vice President of Research and Development